Evolving Treatment Options and Care Management Strategies: A Multiple Sclerosis Update for Pharmacists

Jointly provided by
Impact Education, LLC    
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.

Monday, December 4, 2017
11:30 AM - 1:00 PM
Orange County Convention Center
Room: W104, Level 1
Orlando, FL
A Midday Symposium conducted at the 52nd ASHP Midyear Clinical Meeting and Exhibition.

Click here to download the slides from this symposium.

Check back in 2018 for a free, on-demand CE archive of this symposium.
  • Current evidence-based treatment data
  • MS symptom management strategies
  • Care planning strategies to boost adherence to treatment plans and improve overall coordination
Aimee M. Banks, PharmD, BCPS
Clinical Pharmacist
Vanderbilt University Medical Center
Multiple Sclerosis Clinic
Scott Newsome, DO, MSCS
Assistant Professor of Neurology
Director, Neurology Outpatient Services
Director, Neurology Infusion Center
Johns Hopkins Neuroimmunology and Neuroinfectious Diseases
Johns Hopkins Hospital

This activity is designed to meet the educational needs of health-system pharmacists attending the 52nd ASHP Midyear Clinical Meeting and Exhibition.


Multiple sclerosis (MS) is a chronic immune-mediated degenerative disorder of the central nervous system (CNS). It is estimated that 400,000 individuals in the United States are affected, although this figure may not reflect current numbers as there has not been a robust national assessment of the prevalence of MS since 1975. Onset typically occurs between the ages of 20 and 40 years; consequently, MS is the leading cause of non-traumatic disability in young adults. Women are affected approximately twice as often as men. Yet, despite its relatively low prevalence, MS is characterized by a significant economic burden due to its extensive morbidity and requirement for chronic treatment.

Health-system pharmacists (HSPs) often serve as the intermediary between physicians and patients; a position that provides unique insights into treatment-specific needs of patients with MS. This symposium is designed to educate HSPs on current and emerging MS treatment options, symptom management, multidisciplinary care planning, and patient counseling in order to improve patient care and outcomes in MS patients.


At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Apply current evidence-based treatment data to optimize clinical outcomes for patients with MS
  • Review MS symptom management strategies
  • Employ care planning strategies to boost adherence to treatment plans and improve overall coordination of multidisciplinary MS care
  • Review the impact of effective patient counseling interventions on MS treatment outcomes

Date and Time
Monday, December 4, 2017
11:30 AM - 1:00 PM
Orange County Convention Center
Room: W104, Level 1
Orlando, FL

11:30 AM Opening Comments/Overview and Pre-activity Assessment
Aimee M. Banks, PharmD, BCPS
11:35 AM MS Update: Examining a Rapidly Evolving Treatment Landscape
Scott Newsome, DO, MSCS
12:05 PM Care Management Strategies to Enhance Overall Outcomes for Patients with MS
Aimee M. Banks, PharmD, BCPS
12:30 PM Case Studies
  • Multidisciplinary Care Coordination
  • Symptom Management
  • Patient Counseling
Aimee M. Banks, PharmD, BCPS
12:45 PM Moderated Faculty Panel Discussion and Audience Q&A
Faculty Panel
1:00 PM Closing Comments
Post-activity Assessment and Evaluations

Continuing Pharmacy Education
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - 0809-9999-17-822-L01-P

Type of Activity: Knowledge

For Pharmacists: Upon receipt of the completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. Pharmacist have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Meeting Information
Food and beverage are no longer provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session. Preregistration is for planning purposes only and seating will be available on a first come, first served basis.

Fee Information
Please note: No additional fee is required to attend this CPE activity; however, registration to the 52nd ASHP Midyear Clinical Meeting and Exhibition is required.

Pre-registration will close at 12:00 pm on December 3, 2017.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.